Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01621022 · ClinicalTrials.gov registry record · Phase 4
Bupropion Alone or Combined With Nicotine Gum
A Phase 4 study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- Phase 4
- Development phase
- 608
- Enrollment target
NCT01621022 is a Phase 4 study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 608 participants.
The verdict
NCT01621022, a Phase 4 study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 608 participants
- Enrollment target
Study Summary
Focus of this study was to determine if bupropion was more effective for smoking cessation when used alone or combined with nicotine gum.
Interventions
- DRUG bupropion + nicotine gum
- DRUG Active bupropion-Placebo gum
- DRUG Placebo bupropion-Placebo gum
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 608 participants |
| Start Date | 2001-01 |
| Est. Completion | 2002-10 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01621022
The ClinicalTrials.gov registry entry for NCT01621022 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 608 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which bupropion + nicotine gum is the first listed.
NCT01621022 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01621022 about?
NCT01621022 is a clinical study titled "Bupropion Alone or Combined With Nicotine Gum". Focus of this study was to determine if bupropion was more effective for smoking cessation when used alone or combined with nicotine gum.
What is the current status of trial NCT01621022?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 608 participants. The study started on 2001-01. Estimated completion is 2002-10.
What interventions are being tested in trial NCT01621022?
The interventions under investigation include: bupropion + nicotine gum (DRUG), Active bupropion-Placebo gum (DRUG), Placebo bupropion-Placebo gum (DRUG).
Who is sponsoring clinical trial NCT01621022?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.